We're sorry but your browser is not supported by Marsh.com

For the best experience, please upgrade to a supported browser:

X

PRODUCTS AND SOLUTIONS

Risk Specialists for the Entire SPAC Lifecycle From IPO to De-SPAC and Beyond

The directors and officers of a special purpose acquisition companies (SPACs) face unique exposures and a direct risk to their personal assets as the funds held in SPAC trusts cannot be used to indemnify them. In the absence of a properly crafted insurance program individuals could be forced to dip into their own pockets to cover the defense costs and potential settlements as a result of a claim.

Protecting the personal assets of the board of a SPAC requires a deep understanding of the risks and liabilities faced by directors and officers of these companies as they raise capital, pursue a target, and ultimately complete their business combination. Marsh has assembled a team of specialists who can help SPACs quantify their risks, manuscript their coverages, and secure a policy tailored to their unique exposures.

Under its incorporating documents, a SPAC typically has 24 months from the date of its IPO to either find a suitable target company or liquidate and return funds to investors. Negotiating a merger agreement, commencing due diligence, closing a reverse merger, and operating as a new public company may present multiple risks to the entity, directors and officers and their personal assets.

Directors and officers liability (D&O) policy terms typically align with the SPAC’s due diligence period. Once a target has been identified, Marsh’s SPAC risk specialists will partner with clients to conduct insurance diligence, begin negotiations for new programs, and evaluate options for run-off of prior programs while ensuring coverage for prior acts of the SPAC and its target. 

Marsh’s SPAC Insurance Specialists have served as the insurance broker for 30% of the SPACs that have emerged from IPO in the last 18 months. Marsh is a leading insurance broker in this market, protecting more than $20 billion in SPAC assets. 

Marsh Solutions Can Reduce SPAC D&O Costs by 50%

In response to rapidly increasing premiums and deductibles for SPAC IPO D&O insurance, Marsh has developed a proprietary solution that potentially reduces both by more than 50% compared to the current market. This solution not only reduces upfront costs for SPAC sponsor teams, but also total insurance premiums over the entire SPAC lifecycle, and more appropriately aligns costs with the actual risk exposure in SPAC and de-SPAC transactions. Contact your Marsh representative or use the contact form on this page to get more information.

SPAC IPO Solutions and Services
  • D&O insurance policy terms that line up with a SPAC’s due diligence period.
  • Proprietary SPAC peer benchmarking inclusive of pricing.
  • Pre-negotiated tail coverage to cover claims against the SPAC brought after completion of a business combination.
  • Claims advocacy in the event of a loss.
  • Broad policy conditions including coverage for:
    • Claims brought by prospective targets and PIPE investors.
    • Alleged violations of the Securities Exchange Acts of 1933 and 1934, Dodd-Frank, and Sarbanes-Oxley.
    • Investigations by regulators.

There were 326 federal securities class action lawsuits filed in 2020 – a drop from the record 428 in 2019 -- but the average settlement value in 2020 was $44 million, more than a 50% increase over the 2019 average. These lawsuits highlight the liabilities that SPACs and their directors and officers could face arising from: 

  • Representations made within IPO road shows, S-1s, and quarterly and annual filings.
  • Due diligence and business combination proxy filings.
  • Ongoing operations of post-combination entities.
"De-SPAC" Solutions and Services

The reverse merger that allows a private company to become a listed entity through a SPAC is typically a simpler, shorter, less expensive, and less market-condition-dependent process than a traditional IPO. But there can be unintended consequences and sources of liability for both the SPAC and its target, including, but not limited to:

  • Breakdown of negotiations with a target company.
  • Objections by the target company’s shareholders.
  • Masquerading public shell companies.
  • Private investment in public entity (PIPE) funding.
  • Post-merger stock selloff.
  • Lack of demand for post-merger shares.
  • Limited public company preparedness and experience.
  • Secondary public offerings.
  • De-SPAC performance and financial issues. 

Regardless of a SPAC’s pre-IPO insurance relationships, Marsh’s SPAC specialists can help you manage your risk during the de-SPAC process, which typically commences between two and four months prior to the transaction close, depending on the history and shareholder base of the target and deal structure. Our specialists can assist with:

  • Target Due Diligence
    • Review target company’s insurance.
    • Discuss how best to handle pre-transaction exposure.
    • Develop a plan for all lines of insurance.
  • Strategy Meeting
    • Discuss post-close public company exposures.
    • Review program structure options and alternative approaches as possible levers to optimize risk transfer spend.
  • Negotiating public company D&O program and other corporate insurance
    • Review limits.
    • Forecast retentions and premiums.
    • Evaluate whether and how to cover prior acts under the new public company program.
  • Underwriting Meetings.
    • Coordinate underwriting meetings with all potential carrier partners.
  • Program Negotiation.
    • Negotiate program structure options with the insurance markets.
  • Proposal and Board Presentation.
    • Tailor the proposal and board presentation to capture the placement process and other key areas of focus.

Insurance Considerations in a Reverse Merger (De-SPAC)

A SPAC must conduct appropriate diligence regarding its target to ensure it is free from pending liabilities and not shopping for a new owner to take possession of deal warts. 

Although the number of SPAC-related securities class action claim settlements reached in the last 10 years has been limited, this is partially due to only a small percentage of SPACs completing the de-SPAC process. Litigation, however, has occurred after the business combination, and typically alleges poor due diligence. Litigation after combination typically alleges poor due diligence (for example, discovering that the target company’s financials were not accurate or their business prospects were misleading after the business combination).

Marsh is uniquely positioned to be a SPAC’s risk advisor through the de-SPAC process and for the post-close new company by leveraging:

  • Pre-acquisition insurance and risk management due diligence.
  • Insurance capital solutions to address deal risks including representations and warranties, environmental, and tax.
  • Deep industry knowledge from more than 20 global groups providing industry-specific experience and insights.
  • Customized insurance and risk solutions for the post-close entity, ensuring a smooth transition from SPAC to an operating company.
  • Cost-savings and liquidity strategies.
  • Claims advocacy.
  • Global insurance market access and an understanding of local insurance requirements for global operating companies.
  • Enterprise and operational risk optimization.
  • Digital capabilities. 

Sponsors that remain engaged following business combination can provide the public company with experienced officers and directors. This can be particularly beneficial when a target may have limited experience with the regulatory and compliance requirements of being a public company, and may ensure that appropriate and cost effective insurance is an essential risk management tool.

Additional SPAC Solutions and Services

Transaction risk

  • Pre-acquisition insurance and risk management due diligence.
  • Insurance capital solutions to address deal risks: representations and warranties, environmental, tax liability, successor liability, contingent risk, and other deal related solutions.
  • Post-acquisition insurance placement and transaction related insurance needs: key person, claims-made run-off.
  • Exit solutions that address legacy liabilities in strategic sales, bankruptcies, and initial public offerings (IPO).

Portfolio-level risk

  • Execution of pre-acquisition proposed savings using Marsh’s unique purchasing platform.
  • Optimize costs across a portfolio of investments with portfolio buying approaches.
  • Institute loss reduction strategies to drive down costs for life of investment.

Deep industry knowledge

  • More than 20 global gropus providing industry-specific experience and insights.
  • Customized insurance and risk solutions for the post-close entity, ensuring a smooth transition from SPAC to operating company.
  • Annual metrics based performance review.
  • Cost-savings and liquidity strategies
  • Property and casualty cost take-out strategy and actions
  • Health and benefits options that reduce cost and improve employee retention.
  • Risk finance optimization.
  • Surety solutions to replace LOC obligations.
  • Trade credit to provide balance sheet protection and potential growth levers.

Value-added services

  • Project finance, structured credit, and political risk.
  • Enterprise-level risk optimization assistance (ERM).
  • Oliver Wyman actuarial services.